KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.83 $2.63 Friday, 26th Apr 2024 CGEN stock ended at $1.92. This is 1.05% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.86 to a day high of $1.98.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Mar 07, 2016 $5.79 $6.06 $5.72 $5.87 127 100
Mar 04, 2016 $5.59 $6.09 $5.55 $5.87 200 500
Mar 03, 2016 $5.52 $5.64 $5.48 $5.57 93 000
Mar 02, 2016 $5.18 $5.55 $5.18 $5.51 235 600
Mar 01, 2016 $4.75 $5.29 $4.75 $5.24 184 800
Feb 29, 2016 $4.84 $4.85 $4.60 $4.75 103 800
Feb 26, 2016 $4.79 $4.85 $4.71 $4.73 57 900
Feb 25, 2016 $4.81 $4.85 $4.62 $4.76 58 400
Feb 24, 2016 $4.83 $4.84 $4.59 $4.81 93 900
Feb 23, 2016 $4.90 $4.90 $4.76 $4.82 97 900
Feb 22, 2016 $4.99 $5.03 $4.79 $4.87 152 500
Feb 19, 2016 $4.83 $4.88 $4.75 $4.86 60 500
Feb 18, 2016 $4.96 $4.96 $4.81 $4.81 94 000
Feb 17, 2016 $4.71 $4.95 $4.71 $4.92 116 800
Feb 16, 2016 $4.60 $4.75 $4.52 $4.72 110 600
Feb 12, 2016 $4.67 $4.81 $4.41 $4.50 152 400
Feb 11, 2016 $4.47 $4.60 $4.32 $4.51 208 600
Feb 10, 2016 $4.53 $4.65 $4.50 $4.50 152 400
Feb 09, 2016 $4.50 $4.69 $4.50 $4.51 142 500
Feb 08, 2016 $4.59 $4.62 $4.50 $4.52 281 600
Feb 05, 2016 $4.71 $4.84 $4.65 $4.69 163 300
Feb 04, 2016 $4.50 $4.81 $4.48 $4.74 174 300
Feb 03, 2016 $4.74 $4.74 $4.45 $4.53 170 900
Feb 02, 2016 $4.67 $4.74 $4.57 $4.65 95 500
Feb 01, 2016 $4.72 $4.77 $4.62 $4.72 73 900
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT